Pacer Advisors
KYMR icon

Pacer Advisors’s Kymera Therapeutics KYMR Stock Holding History

Pacer Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68K Buy
+589
New +$50.6K ﹤0.01% 1968
2024
Q3 		– Sell
-517
Closed -$15.4K – 2633
2024
Q2 		$15.4K Sell
517
-464
-47% -$16.1K ﹤0.01% 3478
2024
Q1 		$39.4K Buy
+981
New +$35.1K ﹤0.01% 3265
2021
Q2 		– Sell
-1,208
Closed -$47K – 1489
2021
Q1 		$47K Buy
+1,208
New +$72.7K ﹤0.01% 1443

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Pacer Advisors's KYMR Position: Q2 2026 in Review

Pacer Advisors opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 589 shares worth $68K. The stake represents ﹤0.01% of the portfolio and ranks #1968 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in KYMR as recently as Q2 2024.

Pacer Advisors first reported a position in KYMR in Q1 2021 and has held it in 4 quarters since. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Pacer Advisors held 589 shares of Kymera Therapeutics worth $68K as of Q2 2026.
  • Kymera Therapeutics was a new Pacer Advisors position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1968 holding.
  • Pacer Advisors first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.